Creso Pharma Limited 

Creso Pharma Ltd. specializes in the development, registration, and commercialization of high-quality, pharmaceutical-grade cannabis and hemp-derived nutraceuticals. These health solutions are designed for both human and animal wellness, distributed across Europe, the Middle East, North America, and the Asia Pacific. The company also undertakes the creation and sale of therapeutic products, in addition to cultivating, processing, and supplying cannabis products to retail markets. Among its diverse product line are "anibidiol," a complementary feed for companion animals; "cannaQIX," a nutraceutical containing hemp oil extract, vitamins, and zinc, formulated to reduce stress and support psychological and nervous system functions; and topical skincare items like "cannaDOL," a CBD-based gel featuring a blend of cooling and warming essential oils. Creso Pharma Limited was founded in 2015 and operates from its headquarters in Nedlands, Australia.